Expert Opinions http://www.ip-advocate.org/forum/forum.cfm?ForumID=50 Commentaries on IP issues by<br> experts from business, academia,<br> science and government. en-us Q&A on Critical Issues in University Intellectual Property http://www.ip-advocate.org/forum/topic.cfm?TopicID=119 <p><strong>IPAO Interviews Dr. Galen J. Suppes, PhD<br />Professor of Chemical Engineering, University of Missouri-Columbia</strong></p> <p>&nbsp;</p> <p>There are many nuances and far-reaching ramifications to the handling of invention disclosures at universities than is superficially evident. This question and answer session with Dr. Galen J. Suppes, Professor of Chemical Engineering at the University of Missouri elucidates some of the key issues related to patentable intellectual property a Mon, 29 Jun 2009 16:53:50 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=119 Q&A with Expatriate Scientist Leaving U.S. Frustrated <br>with Barriers to Research http://www.ip-advocate.org/forum/topic.cfm?TopicID=124 <p><strong>IPAO Interviews Dr. David Townsend<br /> Head of SPECT and PET Development, Singapore Bioimaging Consortium<br /> Professor, National University of Singapore</strong><br /><br /> For years Dr. David Townsend has carried out life-saving imaging research at prestigious universities from the University of Geneva to the University of Pittsburgh and then the University of Tennessee. However, after enduring trials with the bureaucracy that has become university technology transfer and compl Thu, 30 Jul 2009 16:14:13 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=124 Solutions For Crisis in Healthcare: How Can Our US Tax Dollars Better Translate Into Medical Benefit? http://www.ip-advocate.org/forum/topic.cfm?TopicID=125 <p><strong>by Fred Mermelstein, PhD</strong></p> <p><strong>Executive Director and Founder, Javelin Pharmaceuticals, Inc.</strong></p> <p>&nbsp;</p> <p>It is readily apparent that the US government dedicates large amounts of taxpayer dollars to support fundamental scientific and medical research with few results of immediate and reasonable impact. The disparity between money spent and return on investment is an untold crisis. Moreover, the <a href="http://www.researchamerica.org/" target="_bl Thu, 30 Jul 2009 16:51:10 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=125 Want to Nurture Innovation?<br>Give University Inventors More Choices http://www.ip-advocate.org/forum/topic.cfm?TopicID=132 <p>IPAO Interviews Dr. Gerald Barnett<br /> Director, Research Technology Enterprise Initiative<br /> University of Washington</p> <p>&nbsp;</p> <p>In this Q&amp;A, IPAO sits down with Gerald Barnett, Director of the <a href="http://rtei.org/" target="_blank">Research Technology Enterprise Initiative</a> at the University of Washington, a 20-year technology transfer veteran with extensive work in university research contracting and intellectual property management and has developed programs th Fri, 18 Sep 2009 21:08:28 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=132 Lost In Translation <br>Unintended Consequences of the Bayh-Dole Act http://www.ip-advocate.org/forum/topic.cfm?TopicID=133 <p>Elizabeth Popp Berman<br /> Assistant Professor<br /> Department of Sociology<br /> University at Albany, SUNY<br /><br /> In 1980, passage by Congress of the Bayh-Dole Act granted universities the right to patent federally funded research. Bayh-Dole was the culmination of fifteen years of effort by government officials and university administrators. Proponents of the legislation cared deeply about getting the results of the vast quantities of taxpayer supported research into the hands of peo Fri, 18 Sep 2009 21:09:04 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=133 Is the New University Mantra “Publish, Patent or Perish�? http://www.ip-advocate.org/forum/topic.cfm?TopicID=134 <p>Elliott C. Kulakowski, PhD</p> <p>President, Research Administration and Management Strategy Group (RAM)</p> <p>&nbsp;</p> <p>Universities are increasing efforts to identify the intellectual property of their faculty and to protect it through their technology commercialization offices (TCO). However, by and large, tenure and promotion systems have not kept pace with the universities' push to commercialize research results.<br /><br /> Historically, tenure and promotion systems focused on t Fri, 18 Sep 2009 21:09:29 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=134 Reconsidering the Bayh-Dole Act http://www.ip-advocate.org/forum/topic.cfm?TopicID=137 <p>In the October 2009 issue of Research Policy, Dr. Martin Kenney and Dr. Donald Patton present their article <a href="http://www.sciencedirect.com/science?_ob=ArticleURL&amp;_udi=B6V77-4X36TM0-1&amp;_user=10&amp;_rdoc=1&amp;_fmt=&amp;_orig=search&amp;_sort=d&amp;_docanchor=&amp;view=c&amp;_acct=C000050221&amp;_version=1&amp;_urlVersion=0&amp;_userid=10&amp;md5=e8aa3fb4d66e7f7be66295a1a224d69b" target="_blank">Reconsidering the Bayh-Dole Act and the Current University Invention Ownership Model. Thu, 24 Sep 2009 17:18:35 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=137 Who Determines the Destiny of University Innovation?<br><span style="font-size:15px">An AUTM debate over the role of the inventor in licensing</span> http://www.ip-advocate.org/forum/topic.cfm?TopicID=171 <p>Held March 18, 2010<br /> AUTM Annual Conference, New Orleans<br /><br /> <em style="color: #7a7a7a;">Dr. Renee Kaswan, former UGA professor and inventor of Restasis&reg;, was invited to take part in the first annual AUTM debate on the "Role of Inventors in Negotiating License Transactions" at its Annual Conference, held this year in New Orleans. What follows is Dr. Kaswan's commentary based on this debate:</em><br /><br /> At present, administrators at most U.S. universities have claimed "to Wed, 31 Mar 2010 18:45:37 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=171 Myriad Ruling Is No Joke http://www.ip-advocate.org/forum/topic.cfm?TopicID=215 <h2>IP Coach Marcel Mongeon shares his opinions on the landmark ruling that invalidated several of Myriad's BRAC patents.</h2> <p>As everyone waits for the Supreme Court of the United States' decision in Bilski &ndash; which may change the fundamental nature of what constitutes a patentable invention &ndash; a trial level judge of the US Federal Court has invalidated gene patents. &nbsp;I note that although the ruling was close to, it was <em><span style="text-decoration: underline;">not</s Wed, 23 Jun 2010 18:53:47 GMT http://www.ip-advocate.org/forum/topic.cfm?TopicID=215